Home/Filings/4/0001179110-17-001724
4//SEC Filing

Allergan plc 4

Accession 0001179110-17-001724

CIK 0001578845operating

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:56 PM ET

Size

8.8 KB

Accession

0001179110-17-001724

Insider Transaction Report

Form 4
Period: 2017-02-01
Stewart Robert A
Pres-Global Operations
Transactions
  • Conversion

    Ordinary Shares, par value $0.0001

    2017-02-01+2,3690 total
    Exercise: $229.32From: 2017-02-01Exp: 2017-02-01Ordinary Shares (2,369 underlying)
  • Tax Payment

    Ordinary Shares, par value $0.0001

    2017-02-01$229.32/sh798$182,99749,771 total
  • Award

    Ordinary Shares, par value $0.0001

    2017-02-01$229.32/sh+2,369$543,25950,569 total
Footnotes (2)
  • [F1]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
  • [F2]Represents performance-based restricted share units ("PSUs") which vested on February 1, 2017, following certification of achievement by issuer of certain performance criteria. Each PSU represented a contingent right to receive ordinary shares of the Issuer equal to the product of the applicable performance multiple and the target number of shares underlying the PSU, as set forth in the award agreement between the Issuer and Reporting Person.

Issuer

Allergan plc

CIK 0001578845

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001578845

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:56 PM ET
Size
8.8 KB